November 16, 2016 06:59 AM ESTUpdated November 17, 03:49 PM
Financing
Startups

GSK vet Ja­son Gard­ner takes the helm of Ma­gen­ta, emerg­ing from stealth with a $48.5M round

John Carroll

Editor & Founder

Ja­son Gard­ner, Ma­gen­ta CEO. Jen Ran­dall Pho­tog­ra­phy.
Ja­son Gard­ner re­turned to his old stomp­ing grounds in Cam­bridge, MA back in the fall of 2014 with …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump team asked Warp Speed leader to head NIH, may seek more tra­di­tion­al pick for role

How did Trump’s FDA pick land? Biotech stocks are up, and ex­ec­u­tives are (most­ly) re­lieved

Bris­tol My­ers re­veals more job cuts in New Jer­sey

Mer­ck halts Phase 3 tri­al with PAH drug Win­re­vair fol­low­ing pos­i­tive in­ter­im da­ta 

In­cyte touts Mon­ju­vi da­ta from Phase 3 fol­lic­u­lar lym­phoma tri­al as it heads to FDA

Gilead buys ex­per­i­men­tal HIV vac­cines from a small Barcelona biotech

A service from the Financial Times